Finallym we suggest the use of Sgk1 inhibitors in the treatment of symptoms (hydrocephalus) associated with cilyopathies in which a dysregulation of the canonical and non-canonical Wnt pathways leads to the stabilization and activation of beta catenin. This evidence concerns the gene SGK1 and Hydrocephalus.